Login to Your Account



Earnings roundup


Wednesday, May 7, 2014

Vivus Inc., of Mountain View, Calif., disclosed total revenue for the first quarter of $36.7 million for the first quarter of 2014, compared to $4.1 million for the first quarter of 2013. Of the total, net product revenue was $9.1 million from sales of obesity drug Qsymia (phentermine/topiramate), compared to $4.1 million for the first quarter of 2013.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription